RE: A new day and closer to news!20 May 2020 08:07
news!
Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and reagents, is pleased to announce that it has entered into an exclusive distribution agreement with Medusa19 Limited ("Medusa19") for direct-to-consumer sales of a saliva-based rapid test for the COVID-19 antigen.